Design and Analysis of Group Sequential Trials for Repeated Measurements When Pipeline Data Occurs: A Tutorial
ABSTRACT Group sequential trials (GST) allow for early stopping of a clinical trial for efficacy or futility, without compromising its validity. Statistical methodology for GST is well established when the endpoint is observed immediately, but less so for endpoints that are measured with a delay, su...
Saved in:
Published in | Statistics in medicine Vol. 44; no. 13-14; pp. e70130 - n/a |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Hoboken, USA
John Wiley & Sons, Inc
01.06.2025
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
ISSN | 0277-6715 1097-0258 1097-0258 |
DOI | 10.1002/sim.70130 |
Cover
Abstract | ABSTRACT
Group sequential trials (GST) allow for early stopping of a clinical trial for efficacy or futility, without compromising its validity. Statistical methodology for GST is well established when the endpoint is observed immediately, but less so for endpoints that are measured with a delay, such as repeatedly measured outcomes for which the primary measurement of interest is taken after several months. The latter can result in pipeline subjects at an interim analysis. These subjects may have early outcome measurements available, but their final endpoint is yet to be observed. Accounting for these early measurements has been shown to increase statistical power. Most importantly, pipeline patients will contribute with additional data after a decision to stop enrollment has been taken at an interim analysis. To make the best use of all available data, these data are ideally incorporated in the final analysis in a formal way. In this tutorial paper, we provide guidance on how to plan a GST with repeated measurements and a delayed endpoint and how to analyze the data resulting from these trials. We discuss existing methods, and also expand on them, for example adding a nonbinding stopping rule for futility and working out the computational details to derive valid p‐values and confidence intervals. We also provide an R package and R code to perform the methods discussed in this paper. |
---|---|
AbstractList | Group sequential trials (GST) allow for early stopping of a clinical trial for efficacy or futility, without compromising its validity. Statistical methodology for GST is well established when the endpoint is observed immediately, but less so for endpoints that are measured with a delay, such as repeatedly measured outcomes for which the primary measurement of interest is taken after several months. The latter can result in pipeline subjects at an interim analysis. These subjects may have early outcome measurements available, but their final endpoint is yet to be observed. Accounting for these early measurements has been shown to increase statistical power. Most importantly, pipeline patients will contribute with additional data after a decision to stop enrollment has been taken at an interim analysis. To make the best use of all available data, these data are ideally incorporated in the final analysis in a formal way. In this tutorial paper, we provide guidance on how to plan a GST with repeated measurements and a delayed endpoint and how to analyze the data resulting from these trials. We discuss existing methods, and also expand on them, for example adding a nonbinding stopping rule for futility and working out the computational details to derive valid p ‐values and confidence intervals. We also provide an R package and R code to perform the methods discussed in this paper. Group sequential trials (GST) allow for early stopping of a clinical trial for efficacy or futility, without compromising its validity. Statistical methodology for GST is well established when the endpoint is observed immediately, but less so for endpoints that are measured with a delay, such as repeatedly measured outcomes for which the primary measurement of interest is taken after several months. The latter can result in pipeline subjects at an interim analysis. These subjects may have early outcome measurements available, but their final endpoint is yet to be observed. Accounting for these early measurements has been shown to increase statistical power. Most importantly, pipeline patients will contribute with additional data after a decision to stop enrollment has been taken at an interim analysis. To make the best use of all available data, these data are ideally incorporated in the final analysis in a formal way. In this tutorial paper, we provide guidance on how to plan a GST with repeated measurements and a delayed endpoint and how to analyze the data resulting from these trials. We discuss existing methods, and also expand on them, for example adding a nonbinding stopping rule for futility and working out the computational details to derive valid p-values and confidence intervals. We also provide an R package and R code to perform the methods discussed in this paper.Group sequential trials (GST) allow for early stopping of a clinical trial for efficacy or futility, without compromising its validity. Statistical methodology for GST is well established when the endpoint is observed immediately, but less so for endpoints that are measured with a delay, such as repeatedly measured outcomes for which the primary measurement of interest is taken after several months. The latter can result in pipeline subjects at an interim analysis. These subjects may have early outcome measurements available, but their final endpoint is yet to be observed. Accounting for these early measurements has been shown to increase statistical power. Most importantly, pipeline patients will contribute with additional data after a decision to stop enrollment has been taken at an interim analysis. To make the best use of all available data, these data are ideally incorporated in the final analysis in a formal way. In this tutorial paper, we provide guidance on how to plan a GST with repeated measurements and a delayed endpoint and how to analyze the data resulting from these trials. We discuss existing methods, and also expand on them, for example adding a nonbinding stopping rule for futility and working out the computational details to derive valid p-values and confidence intervals. We also provide an R package and R code to perform the methods discussed in this paper. ABSTRACT Group sequential trials (GST) allow for early stopping of a clinical trial for efficacy or futility, without compromising its validity. Statistical methodology for GST is well established when the endpoint is observed immediately, but less so for endpoints that are measured with a delay, such as repeatedly measured outcomes for which the primary measurement of interest is taken after several months. The latter can result in pipeline subjects at an interim analysis. These subjects may have early outcome measurements available, but their final endpoint is yet to be observed. Accounting for these early measurements has been shown to increase statistical power. Most importantly, pipeline patients will contribute with additional data after a decision to stop enrollment has been taken at an interim analysis. To make the best use of all available data, these data are ideally incorporated in the final analysis in a formal way. In this tutorial paper, we provide guidance on how to plan a GST with repeated measurements and a delayed endpoint and how to analyze the data resulting from these trials. We discuss existing methods, and also expand on them, for example adding a nonbinding stopping rule for futility and working out the computational details to derive valid p‐values and confidence intervals. We also provide an R package and R code to perform the methods discussed in this paper. |
Author | Baayen, Corine Ozenne, Brice Blanche, Paul Jennison, Christopher |
Author_xml | – sequence: 1 givenname: Corine surname: Baayen fullname: Baayen, Corine email: Corine.Baayen@ferring.com organization: Ferring Pharmaceuticals – sequence: 2 givenname: Paul surname: Blanche fullname: Blanche, Paul organization: University of Copenhagen – sequence: 3 givenname: Christopher surname: Jennison fullname: Jennison, Christopher organization: University of Bath – sequence: 4 givenname: Brice orcidid: 0000-0001-9694-2956 surname: Ozenne fullname: Ozenne, Brice organization: Copenhagen University Hospital, Rigshospitalet |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40514767$$D View this record in MEDLINE/PubMed |
BookMark | eNp10UFP2zAUB3BrYhqF7cAXQJa4wCHtc1zHCbeqMIYEYlo77RgZ53kzSuxgJ0L99rhrtwMSl-fLz3_pvf8ROXDeISEnDKYMIJ9F200lMA4fyIRBJTPIRXlAJpBLmRWSiUNyFOMTAGMil5_I4RwEm8tCToi7wmh_O6pcQxdOtZtoI_WG3gQ_9nSFzyO6waqWrkOakRof6A_sUQ3Y0HtUcQzYJRLprz_o6HfbY2sd0is1KPqg9RjiJV3Q9Tj4bcBn8tGkGPyyf4_Jz6_X6-W37O7h5na5uMs0FwBZoYQSupk_msZI0KZhLGecg8KyNFWlC2i4BtDMGMVlIZSZs6LRhZElB6gEPybnu9w--LRCHOrORo1tqxz6MdY8Z6WUOS9Zomdv6JMfQzrFVuUVSClhG3i6V-Njh03dB9upsKn_XTKBix3QwccY0PwnDOptS3Vqqf7bUrKznX2xLW7eh_Xq9n734xUMM5HL |
Cites_doi | 10.1111/rssb.12225 10.1177/009286150804200402 10.1002/sim.10061 10.1186/s13063-022-06097-z 10.1080/10543400701645439 10.1177/009286150103500407 10.2307/2531502 10.1002/sim.8184 10.1002/sim.4102 10.1186/s13063-020-04526-5 10.1016/0197-2456(92)90017-T 10.1080/10543400701645215 10.1007/s12561-009-9004-3 10.1111/j.2517-6161.1989.tb01433.x 10.1111/j.1467‐9868.2012.01030.x 10.1002/sim.9580 10.1002/9781119238614 10.1111/1541-0420.00081 10.1093/biomet/89.3.699 10.2307/2333237 10.1007/978-3-319-32562-0 10.1093/biomet/74.1.149 10.1214/074921708000000039 |
ContentType | Journal Article |
Copyright | 2025 John Wiley & Sons Ltd. 2025 John Wiley & Sons, Ltd. |
Copyright_xml | – notice: 2025 John Wiley & Sons Ltd. – notice: 2025 John Wiley & Sons, Ltd. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM K9. 7X8 |
DOI | 10.1002/sim.70130 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE MEDLINE - Academic ProQuest Health & Medical Complete (Alumni) |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Statistics Public Health |
EISSN | 1097-0258 |
EndPage | n/a |
ExternalDocumentID | 40514767 10_1002_sim_70130 SIM70130 |
Genre | education Journal Article |
GroupedDBID | --- .3N .GA .Y3 05W 0R~ 10A 123 1L6 1OB 1OC 1ZS 31~ 33P 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52S 52T 52U 52W 52X 53G 5RE 5VS 66C 6PF 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A03 AAESR AAEVG AAHHS AAHQN AAMNL AANHP AANLZ AAONW AASGY AAWTL AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABIJN ABJNI ABOCM ABPVW ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACPOU ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEUYR AEYWJ AFBPY AFFNX AFFPM AFGKR AFWVQ AFZJQ AGHNM AGQPQ AGYGG AHBTC AHMBA AITYG AIURR AIWBW AJBDE AJXKR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMVHM AMYDB ASPBG ATUGU AUFTA AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMNLL BMXJE BNHUX BROTX BRXPI BY8 CS3 D-E D-F DCZOG DPXWK DR2 DRFUL DRSTM DU5 DUUFO EBD EBS EJD EMOBN EX3 F00 F01 F04 F5P FEDTE G-S G.N GNP GODZA H.T H.X HBH HF~ HGLYW HHY HHZ HVGLF HZ~ IX1 J0M JPC KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M67 MEWTI MK4 MRFUL MRSTM MSFUL MSSTM MXFUL MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG P2P P2W P2X P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K RIWAO RJQFR ROL RX1 RYL SAMSI SUPJJ SV3 TN5 UB1 V2E W8V W99 WBKPD WH7 WIB WIH WIK WJL WOHZO WOW WQJ WXSBR WYISQ XBAML XG1 XV2 YHZ ZGI ZXP ZZTAW ~IA ~WT AAMMB AAYXX AEFGJ AGXDD AIDQK AIDYY CITATION CGR CUY CVF ECM EIF NPM K9. 7X8 |
ID | FETCH-LOGICAL-c3500-6a5a5cd4bfdf70cfd1121330ae88f99c60d3c00c1ffa3765af416dc6f78300953 |
IEDL.DBID | DR2 |
ISSN | 0277-6715 1097-0258 |
IngestDate | Fri Jul 11 17:06:33 EDT 2025 Sun Aug 10 11:52:54 EDT 2025 Mon Jul 21 05:36:19 EDT 2025 Thu Aug 14 00:09:57 EDT 2025 Wed Jun 25 09:40:25 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 13-14 |
Keywords | pipeline patients delayed outcomes error spending functions group sequential trials repeated measurements |
Language | English |
License | 2025 John Wiley & Sons Ltd. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3500-6a5a5cd4bfdf70cfd1121330ae88f99c60d3c00c1ffa3765af416dc6f78300953 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0001-9694-2956 |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/sim.70130 |
PMID | 40514767 |
PQID | 3229077705 |
PQPubID | 48361 |
PageCount | 24 |
ParticipantIDs | proquest_miscellaneous_3218772381 proquest_journals_3229077705 pubmed_primary_40514767 crossref_primary_10_1002_sim_70130 wiley_primary_10_1002_sim_70130_SIM70130 |
PublicationCentury | 2000 |
PublicationDate | June 2025 2025-06-00 2025-Jun 20250601 |
PublicationDateYYYYMMDD | 2025-06-01 |
PublicationDate_xml | – month: 06 year: 2025 text: June 2025 |
PublicationDecade | 2020 |
PublicationPlace | Hoboken, USA |
PublicationPlace_xml | – name: Hoboken, USA – name: England – name: New York |
PublicationTitle | Statistics in medicine |
PublicationTitleAlternate | Stat Med |
PublicationYear | 2025 |
Publisher | John Wiley & Sons, Inc Wiley Subscription Services, Inc |
Publisher_xml | – name: John Wiley & Sons, Inc – name: Wiley Subscription Services, Inc |
References | 2007; 17 1989; 45 1987; 74 2022; 23 2019; 38 2008 2011; 30 2007 2003; 59 2022; 41 1992; 13 1989; 51 1957; 44 1982; 69 2023 2000 2022 2021 2020 2002; 89 2013; 75 2017; 79 2019 2016 2024; 43 2013 2020; 21 2008; 42 2001; 35 2009; 1 e_1_2_13_25_1 e_1_2_13_24_1 R Core Team (e_1_2_13_20_1) 2021 e_1_2_13_27_1 e_1_2_13_26_1 e_1_2_13_21_1 Jennison C. (e_1_2_13_5_1) 2013 e_1_2_13_23_1 e_1_2_13_22_1 e_1_2_13_9_1 e_1_2_13_8_1 e_1_2_13_7_1 e_1_2_13_6_1 Fairbanks K. (e_1_2_13_33_1) 1982; 69 Jennison C. (e_1_2_13_2_1) 2000 e_1_2_13_17_1 e_1_2_13_18_1 e_1_2_13_19_1 e_1_2_13_13_1 e_1_2_13_14_1 e_1_2_13_15_1 e_1_2_13_16_1 e_1_2_13_32_1 e_1_2_13_10_1 e_1_2_13_31_1 e_1_2_13_11_1 e_1_2_13_12_1 e_1_2_13_30_1 e_1_2_13_4_1 e_1_2_13_3_1 e_1_2_13_29_1 e_1_2_13_28_1 |
References_xml | – volume: 35 start-page: 1095 issue: 4 year: 2001 end-page: 1112 article-title: Flexible Sample Size Considerations Using Information‐Based Interim Monitoring publication-title: Drug Information Journal – volume: 1 start-page: 95 year: 2009 end-page: 111 article-title: Further Comments on the Alpha‐Spending Function publication-title: Statistics in Biosciences – volume: 74 start-page: 149 issue: 1 year: 1987 end-page: 154 article-title: Design and Analysis of Group Sequential Tests Based on the Type I Error Spending Rate Function publication-title: Biometrika – volume: 51 start-page: 305 year: 1989 end-page: 361 article-title: Interim Analyses: The Repeated Confidence Interval Approach publication-title: Journal of the Royal Statistical Society, Series B – volume: 13 start-page: 106 year: 1992 end-page: 121 article-title: Overrunning and Underrunning in Sequential Clinical Trials publication-title: Controlled Clinical Trials – start-page: 595 year: 2013 end-page: 613 – year: 2007 – year: 2021 – volume: 30 start-page: 3267 year: 2011 end-page: 3284 article-title: Adaptive Increases in Sample Size When Interim Results Are Promising: A Practical Guide With Examples publication-title: Statistics in Medicine – year: 2000 – volume: 21 start-page: 668 year: 2020 article-title: Overrunning in Clinical Trials: Some Thoughts From a Methodological Review publication-title: Trials – year: 2016 – volume: 41 start-page: 5517 issue: 28 year: 2022 end-page: 5536 article-title: Group Sequential Methods for Interim Monitoring of Randomized Clinical Trials With Time‐Lagged Outcome publication-title: Statistics in Medicine – volume: 79 start-page: 1439 year: 2017 end-page: 1462 article-title: A Bayesian Decision Theoretic Model of Sequential Experimentation With Delayed Response publication-title: Journal of the Royal Statistical Society. Series B, Statistical Methodology – volume: 44 start-page: 9 issue: 1/2 year: 1957 end-page: 56 article-title: Restricted Sequential Procedures publication-title: Biometrika – volume: 17 start-page: 1211 year: 2007 end-page: 1225 article-title: Strategies for Including Patients Recruited During Interim Analysis of Clinical Trials publication-title: Journal of Biopharmaceutical Statistics – year: 2008 – volume: 45 start-page: 613 issue: 2 year: 1989 end-page: 617 article-title: Point Estimation Following Group Sequential Tests publication-title: Biometrics – year: 2022 – volume: 42 start-page: 303 year: 2008 end-page: 319 article-title: Recommendations for the Primary Analysis of Continuous Endpoints in Longitudinal Clinical Trials publication-title: Drug Information Journal – year: 2020 – volume: 38 start-page: 3682 year: 2019 end-page: 3702 article-title: Sequential Trials in the Context of Competing Risks: Concepts and Case Study, With R and SAS Code publication-title: Statistics in Medicine – year: 2023 – volume: 75 start-page: 3 issue: 1 year: 2013 end-page: 54 article-title: Group Sequential Tests for Delayed Responses (With Discussion) publication-title: Journal of the Royal Statistical Society, Series B: Statistical Methodology – volume: 59 start-page: 701 year: 2003 end-page: 709 article-title: Incorporating Data Received After a Sequential Trial has Stopped Into the Final Analysis: Implementation and Comparison of Methods publication-title: Biometrics – volume: 89 start-page: 699 year: 2002 end-page: 707 article-title: Sequential Tests and Estimators After Overrunning Based on Maximum‐Likelihood Ordering publication-title: Biometrika – volume: 43 start-page: 1 issue: 12 year: 2024 end-page: 21 article-title: A Two‐Stage Group‐Sequential Design for Delayed Treatment Responses With the Possibility of Trial Restart publication-title: Statistics in Medicine – volume: 17 start-page: 1135 year: 2007 end-page: 1161 article-title: Adaptive Seamless Designs: Selection and Prospective Testing of Hypotheses publication-title: Journal of Biopharmaceutical Statistics – volume: 69 start-page: 69 year: 1982 end-page: 74 article-title: P Values for Tests Using a Repeated Significance Test Design publication-title: Biometrika – year: 2019 – volume: 23 year: 2022 article-title: Planning a Method for Covariate Adjustment in Individually Randomised Trials: A Practical Guide publication-title: Trials – ident: e_1_2_13_24_1 – volume: 69 start-page: 69 year: 1982 ident: e_1_2_13_33_1 article-title: P Values for Tests Using a Repeated Significance Test Design publication-title: Biometrika – ident: e_1_2_13_18_1 doi: 10.1111/rssb.12225 – ident: e_1_2_13_21_1 – ident: e_1_2_13_19_1 – ident: e_1_2_13_22_1 doi: 10.1177/009286150804200402 – ident: e_1_2_13_17_1 doi: 10.1002/sim.10061 – ident: e_1_2_13_23_1 doi: 10.1186/s13063-022-06097-z – ident: e_1_2_13_14_1 doi: 10.1080/10543400701645439 – ident: e_1_2_13_26_1 doi: 10.1177/009286150103500407 – volume-title: R: A Language and Environment for Statistical Computing year: 2021 ident: e_1_2_13_20_1 – ident: e_1_2_13_32_1 doi: 10.2307/2531502 – ident: e_1_2_13_29_1 – ident: e_1_2_13_4_1 doi: 10.1002/sim.8184 – ident: e_1_2_13_16_1 doi: 10.1002/sim.4102 – ident: e_1_2_13_11_1 doi: 10.1186/s13063-020-04526-5 – ident: e_1_2_13_9_1 doi: 10.1016/0197-2456(92)90017-T – volume-title: Group Sequential Methods With Applications to Clinical Trials year: 2000 ident: e_1_2_13_2_1 – ident: e_1_2_13_8_1 – ident: e_1_2_13_30_1 doi: 10.1080/10543400701645215 – ident: e_1_2_13_28_1 doi: 10.1007/s12561-009-9004-3 – ident: e_1_2_13_12_1 doi: 10.1111/j.2517-6161.1989.tb01433.x – ident: e_1_2_13_7_1 doi: 10.1111/j.1467‐9868.2012.01030.x – ident: e_1_2_13_6_1 doi: 10.1002/sim.9580 – ident: e_1_2_13_25_1 doi: 10.1002/9781119238614 – ident: e_1_2_13_13_1 doi: 10.1111/1541-0420.00081 – ident: e_1_2_13_15_1 doi: 10.1093/biomet/89.3.699 – ident: e_1_2_13_31_1 doi: 10.2307/2333237 – ident: e_1_2_13_3_1 doi: 10.1007/978-3-319-32562-0 – ident: e_1_2_13_27_1 doi: 10.1093/biomet/74.1.149 – ident: e_1_2_13_10_1 doi: 10.1214/074921708000000039 – start-page: 595 volume-title: Handbook of Survival Analysis year: 2013 ident: e_1_2_13_5_1 |
SSID | ssj0011527 |
Score | 2.4653075 |
Snippet | ABSTRACT
Group sequential trials (GST) allow for early stopping of a clinical trial for efficacy or futility, without compromising its validity. Statistical... Group sequential trials (GST) allow for early stopping of a clinical trial for efficacy or futility, without compromising its validity. Statistical methodology... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Publisher |
StartPage | e70130 |
SubjectTerms | Clinical Trials as Topic - methods Clinical Trials as Topic - statistics & numerical data Data Interpretation, Statistical delayed outcomes Endpoint Determination - methods error spending functions group sequential trials Humans Models, Statistical pipeline patients repeated measurements Research Design |
Title | Design and Analysis of Group Sequential Trials for Repeated Measurements When Pipeline Data Occurs: A Tutorial |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fsim.70130 https://www.ncbi.nlm.nih.gov/pubmed/40514767 https://www.proquest.com/docview/3229077705 https://www.proquest.com/docview/3218772381 |
Volume | 44 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9RAEB9KH6QgfpwfjVYZxQdf7rqbzWYTfSqepQonYq_QByFs9gOKmivN3Yt_vTu7l5QqgvgSAtl87czO_mZm57cAr3IjmcnbeprzcCiCUzENbpANXkopc2IssrG2avGpPDkrPp7L8x14O9TCJH6IMeBGIyPaaxrguu0Pr0lD-4sfM0V5t2B_uSiJN3_-ZaSO4sN2rZSiLBWXA6sQyw_HO2_ORX8AzJt4NU44x3fh6_CpaZ3Jt9lm3c7Mz99YHP_zX-7BnS0QxaOkOfdhx3UTuLXYptoncDsF9DDVKU1gj2BpYnV-AN08LvxA3VkcaE1w5TFGsvA0Ls8OpuM7LqN-Y0DGGKB-sPvO4uI6LNljmAw6_HxxSWXxDud6rZGIj6_6N3iESyJYCA94CGfH75fvTqbbnRumRkgW_FEttTS2aL31ihlvOTHHCaZdVfm6NiWzwjBmuPc6WDipfcCF1pReVYJAn3gEu92qc_uAwgnHKx3kyHyhTVF5W1ttDalezdo6g5eDDJvLRNDRJCrmvAnd2sRuzeBgkG6zHaN9I4jqXinFZAYvxsthdFHKRHdutaE2vFK0LxvP4HHSivEtBVHHq1Jl8DrK9u-vb04_LOLJk39v-hT2ctpqOAZ8DmB3fbVxzwL-WbfPo6L_Au5Q_xE |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9RAFD7UCloQL6utqVWP4oMvu51cJpOIL8W1bLUpYrfQFwmTuUBpzZbu7ou_vnNmNilVBPElBDK5zbnMd87MfAfgXaI4U0lTDpPYHTIXVAxdGKRdlJLzhBiLtN9bVR3lk5Psyyk_XYOP3V6YwA_RJ9zIMry_JgOnhPTuDWvo_OznSNDE2x24mzmgQaHX-HtPHhV3BVtpkjIXMe94hViy2996ezT6A2LeRqx-yNl_BD-6jw0rTc5Hy0UzUr9-43H83795DA9XWBT3gvI8gTXTDuBetZptH8CDkNPDsFVpABuETAOx81Nox37tB8pWY8dsgjOLPpmFx36FtvMeFzj1Ko4OHKND-871G43VTWZyjm48aPHb2SXtjDc4lguJxH18Nf-AezgljgX3gGdwsv95-mkyXBVvGKqUMxeSSi650lljtRVMWR0TeVzKpCkKW5YqZzpVjKnYWumcHJfWQUOtciuKlHBfugnr7aw1zwFTk5q4kE6QzGZSZYXVpZZakfaVrCkjeNsJsb4MHB11YGNOatette_WCHY68dYrM53XKbHdCyEYj-BNf9kZGM2ayNbMltQmLgSVZosj2Apq0b8lI_Z4kYsI3nvh_v319fFB5U-2_73pa7g_mVaH9eHB0dcXsJFQ5WGf_9mB9cXV0rx0cGjRvPJafw3j1AM_ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LaxRBEC5ihBAQH-trNGopHrzspufZM3oKrkuibghmAzkIQ08_IKizS3b34q-3qntnQhRBvAwD0_Pqqur-qqrra4DXic6FTppqmMR0yMipGJIbZMhLKfKEGYuMr62aHheHZ9nH8_x8C951tTCBH6IPuLFl-PGaDXxh3P4Vaejy4sdIct7tBtzMCkISjIi-9NxRcbdfK-coCxnnHa2QSPb7W69PRn8gzOuA1c84kzvwtfvWsNDk22i9akb65280jv_5M3fh9gaJ4kFQnXuwZdsB7Ew3ufYB3AoRPQyFSgPYZVwaaJ3vQzv2Kz9QtQY7XhOcO_ShLDz167Np7PiOM6_gSNAYCevTwG8NTq_ikkuk2aDFk4sF18VbHKuVQmY-vly-xQOcMcMCPeABnE0-zN4fDjdbNwx1mgtySFWucm2yxhknhXYmZuq4VChblq6qdCFMqoXQsXOKhrhcOQKGRhdOlimjvvQhbLfz1j4GTG1q41KRHIXLlM5KZyqjjGbdq0RTRfCqk2G9CAwddeBiTmrq1tp3awR7nXTrjZEu65S57qWUIo_gZX-ZzItzJqq18zW3iUvJG7PFETwKWtG_JWPueFnICN542f799fXp0dSfPPn3pi9g52Q8qT8fHX96CrsJbzvsgz97sL26XNtnhIVWzXOv878A2owB7g |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Design+and+Analysis+of+Group+Sequential+Trials+for+Repeated+Measurements+When+Pipeline+Data+Occurs%3A+A+Tutorial&rft.jtitle=Statistics+in+medicine&rft.au=Baayen%2C+Corine&rft.au=Blanche%2C+Paul&rft.au=Jennison%2C+Christopher&rft.au=Ozenne%2C+Brice&rft.date=2025-06-01&rft.pub=Wiley+Subscription+Services%2C+Inc&rft.issn=0277-6715&rft.eissn=1097-0258&rft.volume=44&rft.issue=13-14&rft_id=info:doi/10.1002%2Fsim.70130&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0277-6715&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0277-6715&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0277-6715&client=summon |